FDA.reportPublic FDA data

NDC 71719-2030-2 - Vizumax HD

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
71719-2030
Requested NDC
71719-2030-2
Package NDCs from labels
71719-2030-1, 71719-2030-2, 71719-2030-3
Manufacturer
Vizumax Diagnostics LLC
Effective date
2021-10-04
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Vizumax HD - Vizumax Diagnostics LLCVizumax Diagnostics LLC2021-10-04HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
71719-2030-12022-07-29These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2030-22022-07-29These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2030-32022-07-29These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2030-12021-10-04These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2030-22021-10-04These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2030-32021-10-04These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2030-12021-01-29These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2030-22021-01-29These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.
71719-2030-32021-01-29These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71719-2030-1Vizumax HD340 g in 1 BOTTLE, PLASTICPOWDER, FOR SUSPENSION34011
71719-2030-2Vizumax HD5000 g in 1 PAILPOWDER, FOR SUSPENSION500011
71719-2030-3Vizumax HD25000 g in 1 PAILPOWDER, FOR SUSPENSION2500011

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71719-2030VIZUMAX HD (BARIUM SULFATE) POWDER, FOR SUSPENSION [VIZUMAX DIAGNOSTICS LLC]113 package rows20211005_6366e9e9-384b-7fcb-e053-2a91aa0a072c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 14 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Varibar Thin HoneyBARIUM SULFATEE-Z-EM Canada Inc37bf7f08-5486-e570-7f80-0e0ee5cd33e82026-05-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Varibar PuddingBARIUM SULFATEE-Z-EM Canada Inc553285e2-d0e9-8b7b-4766-a0a6b9496f872026-05-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Varibar NectarBARIUM SULFATEE-Z-EM Canada Inc5e7045f7-b771-d8af-ce30-be95b2597c102026-05-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
ENTERO Vu 24%BARIUM SULFATEE-Z-EM Canada Inc83a06a8e-93db-a59b-933c-5882127bce7c2026-05-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
E-Z-PaqueBARIUM SULFATEE-Z-EM Canada Inc7225868a-4037-c96a-44e3-3326d36cbedc2026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
E-Z-PaqueBARIUM SULFATEE-Z-EM Canada Inc2ecea1ab-66c8-4eb0-8503-6d6b41b513282026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Varibar Thin LiquidBARIUM SULFATEE-Z-EM Canada Inc59493c83-3941-cc84-cc37-a8696ae428732026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Readi-Cat 2 Berry SmoothieBARIUM SULFATEE-Z-EM Canada Incd2d293d5-dcc9-0d3f-58ed-686ef0132d7c2026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
E-Z-HDBARIUM SULFATEE-Z-EM Canada Inca4330804-7179-472a-91cb-84bbd5079bb82026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Tagitol VBARIUM SULFATEE-Z-EM Canada Inc30c68756-c7db-bf50-9cd5-ef4b0c7ab1d02026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
E-Z-PasteBARIUM SULFATEE-Z-EM Canada Inc704132ea-4986-0b2c-2dd4-de89c0282a152025-12-18Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Varibar HoneyBARIUM SULFATEE-Z-EM Canada Incd404b381-a180-4a85-6863-0a0d2bcabc522025-12-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
E-Z-DiskBARIUM SULFATEE-Z-EM, INC.c759668b-5cf1-b237-00c8-a5e4733b6f4c2025-09-29Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
cd86fd02-3d4a-1747-e053-2995a90a66af6366e9e9-384b-7fcb-e053-2a91aa0a072c2021-10-04Warnings, Adverse reactionsExact identifier
spl id: cd86fd02-3d4a-1747-e053-2995a90a66af
spl set id: 6366e9e9-384b-7fcb-e053-2a91aa0a072c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.